The association between Helicobacter pylori eradication in peptic ulcer patients and gastric cancer? Investigation in an East-Asian population

Document Type : Brief Report

Author

Mashhad univ med sci

Abstract

H. pylori is Gram-negative, microaerophilic, and motile bacteria which colonized in human stomach of nearly 50% of world population; there are several evidence for chronic colonization with H. pylori that significantly increased the risk of gastric cancer development (15). Eradication of H. pylori infection can have reduced the risk of gastric cancer as well as reduction of H. pylori in young population as reservoir of infection (5,10). According to literatures, the mother to child transmission is predominant rout of H. pylori transmission in Japanese population; therefore, eradication of H. pylori infection can be considered as appropriated strategy for reducing both of gastric cancer as well as H. pylori infection burden (16). There are several literatures in relation to efficacy of H. pylori eradication for prevention of gastric cancer development in asymptomatic carrier and patients with endoscopic resections (7,8); however, we evaluated the efficacy of H. pylori eradication in reduction of gastric cancer in patients with history of peptic ulcer. We are suggested that H. pylori infection should be eradicated in peptic ulcer patients in order to reducing the risk of develop to gastric cancer.

Keywords

References


1. Keikha M. Is there a relationship between Helicobacter pylori vacA i1 or i2 alleles and development into peptic ulcer and gastric cancer? A meta-analysis study on an Iranian population. New Microbes New Infect. 2020 Jul 3;36:100726. doi: 10.1016/j.nmni.2020.100726. PMID: 32714559; PMCID: PMC7378689.
2. Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res. 1998 Oct 1;58(19):4255-9. PMID: 9766647.
3. Karbalaei M, Keikha M. Potential association between the hopQ alleles of Helicobacter pylori and gastrointestinal diseases: A systematic review and meta-analysis. Meta Gene. 2020:100816.
4. Nozaki K, Shimizu N, Ikehara Y, Inoue M, Tsukamoto T, Inada K, Tanaka H, Kumagai T, Kaminishi M, Tatematsu M. Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils. Cancer Sci. 2003 Mar;94(3):235-9. doi: 10.1111/j.1349-7006.2003.tb01426.x. PMID: 12824915.
5. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001 Sep 13;345(11):784-9. doi: 10.1056/NEJMoa001999. PMID: 11556297.
6. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK, Chen JS; China Gastric Cancer Study Group. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004 Jan 14;291(2):187-94. doi: 10.1001/jama.291.2.187. PMID: 14722144.
7. TTerasawa T, Hamashima C, Kato K, Miyashiro I, Yoshikawa T, Takaku R, Nishida H. Helicobacterpylori eradication treatment for gastric carcinoma prevention in asymptomatic or dyspeptic adults: systematic review and Bayesian meta-analysis of randomised controlled trials. BMJ Open. 2019 Sep 20;9(9):e026002. doi: 10.1136/bmjopen-2018-026002. PMID: 31542733; PMCID: PMC6756423.
8. Sugimoto M, Murata M, Yamaoka Y. Chemoprevention of gastric cancer development after Helicobacter pylori eradication therapy in an East Asian population: Meta-analysis. World J Gastroenterol. 2020;26(15):1820-1840. doi:10.3748/wjg.v26.i15.1820
9. Youssefi M, Tafaghodi M, Farsiani H, Ghazvini K, Keikha M. Helicobacter pylori infection and autoimmune diseases; Is there an association with systemic lupus erythematosus, rheumatoid arthritis, autoimmune atrophy gastritis and autoimmune pancreatitis? A systematic review and meta-analysis study. J Microbiol Immunol Infect. 2020 Aug 28:S1684-1182(20)30209-7. doi: 10.1016/j.jmii.2020.08.011. Epub ahead of print. PMID: 32891538.
10. Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, Oguma K, Okada H, Shiratori Y. The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol. 2005 May;100(5):1037-42. doi: 10.1111/j.1572-0241.2005.41384.x. PMID: 15842576.
11. Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, Oguma K. Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases. J Gastroenterol. 2007 Jan;42 Suppl 17:21-7. doi: 10.1007/s00535-006-1924-9. PMID: 17238021.
12. Mabe K, Takahashi M, Oizumi H, et al. Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer?. World J Gastroenterol. 2009;15(34):4290-4297. doi:10.3748/wjg.15.4290
13. Wu CY, Kuo KN, Wu MS, Chen YJ, Wang CB, Lin JT. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology. 2009 Nov;137(5):1641-8.e1-2. doi: 10.1053/j.gastro.2009.07.060. Epub 2009 Aug 5. PMID: 19664631.
14. Take S, Mizuno M, Ishiki K, Hamada F, Yoshida T, Yokota K, Okada H, Yamamoto K. Seventeen-year effects of eradicating Helicobacter pylori on the prevention of gastric cancer in patients with peptic ulcer; a prospective cohort study. J Gastroenterol. 2015 Jun;50(6):638-44. doi: 10.1007/s00535-014-1004-5. Epub 2014 Oct 29. PMID: 25351555.
15. Karbalaei M, Khorshidi M, Sisakht-pour B, Ghazvini K, Farsiani H, Youssefi M, Keikha M, et al. What are the effects of IL-1β (rs1143634), IL-17A promoter (rs2275913) and TLR4 (rs4986790) gene polymorphism on the outcomes of infection with H. pylori within as Iranian population; A systematic review and meta-analysis. Gene Reports. 2020:100735.
16. Konno M, Yokota S, Suga T, Takahashi M, Sato K, Fujii N. Predominance of mother-to-child transmission of Helicobacter pylori infection detected by random amplified polymorphic DNA fingerprinting analysis in Japanese families. Pediatr Infect Dis J. 2008 Nov;27(11):999-1003. doi: 10.1097/INF.0b013e31817d756e. PMID: 18845980.
Trends in Pharmaceutical Sciences
Volume 6, Issue 4
December 2020
Pages 279-282

Files

Share

How to cite

Statistics